603077.SH
和邦生物
SSE · Basic Materials · Chemicals · CN
CNY 2.42
+2.11%Year over year
Reported trailing growth
- Revenue
- -17.2%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +93.1%
- Operating cash flow
- +36.2%
Forward estimates
Based on analyst estimates
- Revenue
- -59.2%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -18.0%
- EBITDA
- -58.2%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +71.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026